NP47923a Adalimumab, NP47923b Tocilizumab and NP47923c Eculizumab

Tender description

Supply of adalimumab, tocilizumab and eculizumab to NHS Scotland. Lot 1: NP47923a Adalimumab Supply of Adalimumab pre-filled pens/devices and pre-filled syringes to NHS Scotland. The Authority intends to award this Lot as an unranked multi-supplier framework per product line to a maximum of six (6) Framework Participants. This Lot will be awarded from 1 March 2024, for 24 months, with an expiry date of 28 February 2026. This Lot has the option to extend by any number of periods, up to the maximum 24 months. Full details of Goods and volumes can be found within the ITT documents. Lot 2: NP47923b Tocilizumab Supply of tocilizumab pre-filled pens/devices, pre-filled syringes and vials to NHS Scotland. The Authority intends to award this Lot as an unranked multi-supplier framework per product line to a maximum of three (3) Framework Participants. This Lot will be awarded from 1 March 2024, for 12 months, with an expiry date of 28 February 2025. This Lot has the option to extend by any number of periods, up to the maximum 36 months. Full details of Goods and volumes can be found within the ITT documents. Lot 3: NP47923c Eculizumab Supply of eculizumab vials to NHS Scotland. The Authority intends to award this Lot as an unranked multi-supplier framework per product line to a maximum of three (3) Framework Participants. This Lot will be awarded from 1 March 2024, for 24 months, with an expiry date of 28 February 2026. This Lot has the option to extend by any number of periods, up to the maximum 24 months. Full details of Goods and volumes can be found within the ITT documents.